natgillin/translations-raw huggingface dataset:
The following is added in point 15zh (Regulation (EC) No 1394/2007 of the European Parliament and of the Council):
U točki 15.zh (Uredba (EZ) br. 1394/2007 Europskog parlamenta i Vijeća) dodaje se sljedeće:
The texts of Regulation (EU) No 1235/2010, as corrected by OJ L 201, 27.7.2012, p. 138, and Directive 2010/84/EU, as corrected by OJ L 21, 25.1.2011, p. 8 and OJ L 276, 21.10.2011, p. 63, in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.
Tekstovi Uredbe (EU) br. 1235/2010, kako je ispravljena u SL L 201, 27.7.2012., str. 138. i Direktive 2010/84/EU, kako je ispravljena u SL L 21, 25.1.2011., str. 8. i u SL L 276, 21.10.2011., str. 63. na islandskom i norveškom jeziku, koji se objavljuju u Dodatku o EGP-u Službenom listu Europske unije, vjerodostojni su.
This Decision shall enter into force on 9 October 2013 or on the day following the last notification under Article 103(1) of the EEA Agreement, whichever is the later [3].
Ova Odluka stupa na snagu 9. listopada 2013. ili prvog dana nakon što je posljednja obavijest iz članka 103. stavka 1. Sporazuma o EGP-u podnesena ovisno o tome koji je datum kasniji [3].
For Liechtenstein, this Decision shall enter into force on the same day or on the day of entry into force of the amendments to the Agreement between Liechtenstein and Austria laying down the technical details for Liechtenstein’s recognition of Austrian marketing authorisations within the decentralised procedure (DCP) and the mutual recognition procedure (MRP), whichever is the later.
Za Lihtenštajn ova Odluka stupa na snagu istog dana ili dana stupanja na snagu izmjena Sporazuma između Lihtenštajna i Austrije o utvrđivanju tehničkih detalja za lihtenštajnsko priznavanje austrijskog odobrenja za stavljanje lijeka u promet unutar decentraliziranog postupka i postupka uzajamnog priznavanja, ovisno o tome koji je kasniji.
OJ L 348, 31.12.2010, p. 1.
SL L 348, 31.12.2010., str. 1.
OJ L 348, 31.12.2010, p. 74.
SL L 348, 31.12.2010., str. 74.
Constitutional requirements indicated.
Ustavni zahtjevi su navedeni.
Directive 2011/62/EU of the European Parliament and of the Council of 8 June 2011 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use, as regards the prevention of the entry into the legal supply chain of falsified medicinal products [1] is to be incorporated into the EEA Agreement,
Direktivu 2011/62/EU Europskog parlamenta i Vijeća od 8. lipnja 2011. o izmjeni Direktive 2001/83/EZ o zakoniku Zajednice koji se odnosi na lijekove za primjenu kod ljudi, u svrhu prevencije unosa krivotvorenih lijekova u legalni opskrbni lanac [1] treba uključiti u Sporazum.
The following indent is added in point 15q (Directive 2001/83/EC of the European Parliament and of the Council) of Chapter XIII of Annex II to the EEA Agreement:
U poglavlje XIII.
32011 L 0062: Directive 2011/62/EU of the European Parliament and of the Council of 8 June 2011 (OJ L 174, 1.7.2011, p. 74).’
32011 L 0062: Direktiva 2011/62/EU Europskog parlamenta i Vijeća od 8. lipnja 2011. (SL L 174, 1.7.2011., str. 74.).”
The text of Directive 2011/62/EU in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.
Tekstovi Direktive 2011/62/EU na islandskom i norveškom jeziku, koji se objavljuju u Dodatku o EGP-u Službenom listu Europske unije, vjerodostojni su.
This Decision shall enter into force on 9 October 2013, provided that all the notifications under Article 103(1) of the EEA Agreement have been made to the EEA Joint Committee [2].
Ova Odluka stupa na snagu 9. listopada 2013., pod uvjetom da su sve obavijesti iz članka 103. stavka 1. Sporazuma podnesene Zajedničkom odboru EGP-a [2].
OJ L 174, 1.7.2011, p. 74.
SL L 174, 1.7.2011., str. 74.
Directive 2012/26/EU of the European Parliament and of the Council of 25 October 2012 amending Directive 2001/83/EC as regards pharmacovigilance [1] is to be incorporated into the EEA Agreement.
Direktivu 2012/26/EU Europskog parlamenta i Vijeća od 25. listopada 2012. o izmjeni Direktive 2001/83/EZ u pogledu farmakovigilancije [1] treba uključiti u Sporazum o EEA-u.
32012 L 0026: Directive 2012/26/EU of the European Parliament and of the Council of 25 October 2012 (OJ L 299, 27.10.2012, p. 1).’
32012 L 0026: Direktiva 2012/26/EU Europskog parlamenta i Vijeća od 25. listopada 2012. (SL L 299, 27.10.2012., str. 1.).”
The texts of Directive 2012/26/EU in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.
Tekstovi Direktive 2012/26/EU na islandskom i norveškom jeziku, koji se objavljuju u Dodatku o EGP-u Službenom listu Europske unije, vjerodostojni su.
OJ L 299, 27.10.2012, p. 1.
SL L 299, 27.10.2012., str. 1.
Commission Implementing Decision 2013/51/EU of 23 January 2013 on the assessment of a third country’s regulatory framework applicable to active substances of medicinal products for human use and of the respective control and enforcement activities pursuant to Article 111b of Directive 2001/83/EC of the European Parliament and of the Council [1] is to be incorporated into the EEA Agreement.
Provedbenu odluku Komisije 2013/51/EU od 23. siječnja 2013. o procjeni regulatornog okvira treće zemlje primjenljivog na aktivne tvari u lijekovima za primjenu kod ljudi i odgovarajuće aktivnosti kontrole i izvršenja prema članku 111.b Direktive 2001/83/EZ Europskog parlamenta i Vijeća [1] treba inkorporirati u Sporazum o EGP-u.
The following point is inserted after point 15q (Directive 2001/83/EC of the European Parliament and of the Council) of Chapter XIII of Annex II to the EEA Agreement:
U poglavlje XIII.
32013 D 0051: Commission Implementing Decision 2013/51/EU of 23 January 2013 on the assessment of a third country’s regulatory framework applicable to active substances of medicinal products for human use and of the respective control and enforcement activities pursuant to Article 111b of Directive 2001/83/EC of the European Parliament and of the Council (OJ L 21, 24.1.2013, p. 36).’
32013 D 0051: Provedbena odluka Komisije 2013/51/EU od 23. siječnja 2013. o procjeni regulatornog okvira treće zemlje primjenljivog na aktivne tvari u lijekovima za primjenu kod ljudi i odgovarajuće aktivnosti kontrole i izvršenja prema članku 111.b Direktive 2001/83/EZ Europskog parlamenta i Vijeća (SL L 21, 24.1.2013., str. 36.).”
The text of Implementing Decision 2013/51/EU in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.
Tekstovi Provedbene odluke 2013/51/EU na islandskom i norveškom jeziku, koji se objavljuju u Dodatku o EGP-u Službenom listu Europske unije, vjerodostojni su.
OJ L 21, 24.1.2013, p. 36.
SL L 21, 24.1.2013., str. 36.
Commission Implementing Decision 2012/715/EU of 22 November 2012 establishing a list of third countries with a regulatory framework applicable to active substances for medicinal products for human use and the respective control and enforcement activities ensuring a level of protection of public health equivalent to that in the Union, in accordance with Directive 2001/83/EC of the European Parliament and of the Council [1] is to be incorporated into the EEA Agreement.
Provedbenu odluka Komisije 2012/715/EU od 22. studenoga 2012. o uspostavi popisa trećih zemalja s regulatornim okvirom primjenjivim na aktivne tvari za lijekove za primjenu kod ljudi i odgovarajuće aktivnosti kontrole i izvršenja kojima se osigurava zaštita javnog zdravlja ekvivalentna zaštiti u Uniji, u skladu s Direktivom 2001/83/EZ Europskog parlamenta i Vijeća [1] treba inkorporirati u Sporazum o EGP-u.
The following point is inserted after point 15qa (Commission Implementing Decision 2013/51/EU) of Chapter XIII of Annex II to the EEA Agreement:
U poglavlje XIII.
32012 D 0715: Commission Implementing Decision 2012/715/EU of 22 November 2012 establishing a list of third countries with a regulatory framework applicable to active substances for medicinal products for human use and the respective control and enforcement activities ensuring a level of protection of public health equivalent to that in the Union, in accordance with Directive 2001/83/EC of the European Parliament and of the Council (OJ L 325, 23.11.2012, p. 15).’
32012 D 0715: Provedbena odluka Komisije 2012/715/EU od 22. studenoga 2012. o uspostavi popisa trećih zemalja s regulatornim okvirom primjenjivim na aktivne tvari za lijekove za primjenu kod ljudi i odgovarajuće aktivnosti kontrole i izvršenja kojima se osigurava zaštita javnog zdravlja ekvivalentna zaštiti u Uniji, u skladu s Direktivom 2001/83/EZ Europskog parlamenta i Vijeća (SL L 325, 23.11.2012., str. 15.).”
The texts of Implementing Decision 2012/715/EU in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.
Tekstovi Provedbene odluke 2012/715/EU na islandskom i norveškom jeziku, koji se objavljuju u Dodatku o EGP-u Službenom listu Europske unije, vjerodostojni su.
OJ L 325, 23.11.2012, p. 15.
SL L 325, 23.11.2012., str. 15.
Regulation (EU) No 1027/2012 of the European Parliament and of the Council of 25 October 2012 amending Regulation (EC) No 726/2004 as regards pharmacovigilance [1] is to be incorporated into the EEA Agreement.
Uredbu (EU) br. 1027/2012 Europskog parlamenta i Vijeća od 25. listopada 2012. o izmjeni Uredbe (EZ) br. 726/2004 u pogledu farmakovigilancije [1] treba inkorporirati u Sporazum o EGP-u.
The following indent is added in point 15zb (Regulation (EC) No 726/2004 of the European Parliament and of the Council) of Chapter XIII of Annex II to the EEA Agreement:
U poglavlje XIII.
32012 R 1027: Regulation (EU) No 1027/2012 of the European Parliament and of the Council of 25 October 2012 (OJ L 316, 14.11.2012, p. 38).’
32012 R 1027: Uredba (EU) br. 1027/2012 Europskog parlamenta i Vijeća od 25. listopada 2012. (SL L 316, 14.11.2012., str. 38.).”
The texts of Regulation (EU) No 1027/2012 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.
Tekstovi Uredbe (EU) br. 1027/2012 na islandskom i norveškom jeziku, koji se objavljuju u Dodatku o EGP-u Službenom listu Europske unije, vjerodostojni su.
This Decision shall enter into force on 9 October 2013, provided that all the notifications under Article 103(1) of the EEA Agreement have been made [2], or on the day of the entry into force of Decision of the EEA Joint Committee No 158/2013 of 8 October 2013 [3], whichever is the later.
Ova Odluka stupa na snagu 9. listopada 2013. pod uvjetom da su sve obavijesti iz članka 103. stavka 1. Sporazuma o EGP-u podnesene [2] ili na dan stupanja na snagu Odluke Zajedničkog odbora EGP-a br. 158/2013 od 8. listopada 2013. [3], ovisno o datumu koji nastupi kasnije.
OJ L 316, 14.11.2012, p. 38.
SL L 316, 14.11.2012., str. 38.
See page 10 of this Official Journal.
Vidjeti stranicu 10. ovog Službenog lista.
Directive 2010/53/EU of the European Parliament and of the Council of 7 July 2010 on standards of quality and safety of human organs intended for transplantation [1], as corrected by OJ L 243, 16.9.2010, p. 68, is to be incorporated into the EEA Agreement.
Direktivu 2010/53/EU Europskog parlamenta i Vijeća od 7. srpnja 2010. o standardima kvalitete i sigurnosti ljudskih organa namijenjenih transplantaciji [1], kako je ispravljena u SL L 243, 16.9.2010., str. 68., treba inkorporirati u Sporazum o EGP-u.
The following is inserted after point 15zm (Commission Regulation (EC) No 668/2009) of Chapter XIII of Annex II to the EEA Agreement:
U poglavlje XIII.
32010 L 0053: Directive 2010/53/EU of the European Parliament and of the Council of 7 July 2010 on standards of quality and safety of human organs intended for transplantation (OJ L 207, 6.8.2010, p. 14), as corrected by OJ L 243, 16.9.2010, p. 68.
32010 L 0053: Direktiva 2010/53/EU Europskog parlamenta i Vijeća od 7. srpnja 2010. o standardima kvalitete i sigurnosti ljudskih organa namijenjenih transplantaciji (SL L 207, 6.8.2010., str. 14.), kako je ispravljena u SL L 243, 16.9.2010., str. 68.
The provisions of the Directive shall, for the purposes of this Agreement, be read with the following adaptation:
Odredbe Direktive, u smislu ovog Sporazuma, sadrže sljedeće prilagodbe:
This Directive shall not apply to Liechtenstein, with the exception of Articles 15 and 16.
Ova se Direktiva ne odnosi na Lihtenštajn, osim članaka 15. i 16.
The definitions in Article 3 and general provisions in Articles 17(2)(h) and 23 shall only apply to Liechtenstein as far as necessary for transposing Articles 15 and 16 of the Directive.’
Definicije u članku 3. i opće odredbe u člancima 17. stavku 2. točki (h) i 23. odnose se samo na Lihtenštajn, u mjeri potrebnoj za prenošenje članaka 15. i 16. Direktive.”
The texts of Directive 2010/53/EU, as corrected by OJ L 243, 16.9.2010, p. 68 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.
Tekstovi Direktive 2010/53/EU, kako su ispravljeni u SL L 243, 16.9.2010., str. 68. na islandskom i norveškom jeziku, koji se objavljuju u Dodatku o EGP-u Službenom listu Europske unije, vjerodostojni su.
This Decision shall enter into force on 9 October 2013, provided that all the notifications under Article 103(1) of the EEA Agreement have been made to the EEA Joint Committee [2].
Ova Odluka stupa na snagu 9. listopada 2013. pod uvjetom da su sve obavijesti iz članka 103. stavka 1. Sporazuma o EGP-u podnesene Zajedničkom odboru EGP-a [2].
OJ L 207, 6.8.2010, p. 14.
SL L 207, 6.8.2010., str. 14.
Declaration by the EFTA States to Decision No 164/2013 of 8 October 2013 incorporating Directive 2010/53/EU of the European Parliament and of the Council of 7 July 2010 on standards of quality and safety of human organs intended for transplantation into the EEA Agreement
Izjava država EFTA-e uz Odluku br. 164/2013 od 8. listopada 2013. o uključivanju Direktive 2010/53/EU Europskog parlamenta i Vijeća od 7. srpnja 2010. o standardima kvalitete i sigurnosti ljudskih organa namijenjenih transplantaciji u Sporazum o EGP-u
‘Directive 2010/53/EU of the European Parliament and of the Council of 7 July 2010 on standards of quality and safety of human organs intended for transplantation, based on Article 168 of the Treaty on the Functioning of the European Union, constitutes an important part of European health legislation and corresponds to the health policy of the EFTA States.
„Direktiva 2010/53/EU Europskog parlamenta i Vijeća od 7. srpnja 2010. o standardima kvalitete i sigurnosti ljudskih organa namijenjenih transplantaciji, na temelju članka 168. Ugovora o funkcioniranju Europske unije, čini važan dio zdravstvenog zakonodavstva i odgovara uvjetima zdravlja država EFTA-e.
The EEA Agreement does not provide a legal basis for public health equivalent to that of Article 168 of the Treaty on the Functioning of the European Union.
Sporazum o EGP-u ne pruža pravni temelj za javno zdravstvo jednako onome iz članka 168. Ugovora o funkcioniranju Europske unije.
The incorporation of this Directive is thus without prejudice to the scope of the EEA Agreement.
Inkorporacija ove Direktive ne dovodi u pitanje područje primjene Sporazuma o EGP-u.
This declaration is without prejudice to Article 118 of the EEA Agreement.’
Ova izjava ne dovodi u pitanje članak 118. Sporazuma o EGP-u.”
Commission Directive 2013/7/EU of 21 February 2013 amending Directive 98/8/EC of the European Parliament and of the Council to include Alkyl (C12-16) dimethylbenzyl ammonium chloride as an active substance in Annex I thereto [1] is to be incorporated into the EEA Agreement.
Direktivu Komisije 2013/7/EU od 21. veljače 2013. o izmjeni Direktive 98/8/EZ Europskog parlamenta i Vijeća radi uvrštavanja alkil (C12-16) dimetilbenzil amonijevog klorida kao aktivne tvari u njezin Prilog I. [1] treba inkorporirati u Sporazum o EGP-u.
The following indent is added in point 12n (Directive 98/8/EC of the European Parliament and of the Council) of Chapter XV of Annex II to the EEA Agreement:
U poglavlje XV.
32013 L 0007: Commission Directive 2013/7/EU of 21 February 2013 (OJ L 49, 22.2.2013, p. 66).’
32013 L 0007: Uredba Komisije 2013/7/EU od 21. veljače 2013. (SL L 49, 22.2.2013., str. 66.).”
The texts of Directive 2013/7/EU in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.
Tekstovi Direktive 2013/7/EU na islandskom i norveškom jeziku, koji se objavljuju u Dodatku o EGP-u Službenom listu Europske unije, vjerodostojni su.
OJ L 49, 22.2.2013, p. 66.
SL L 49, 22.2.2013., str. 66.
Commission Regulation (EU) No 126/2013 of 13 February 2013 amending Annex XVII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) [1] is to be incorporated into the EEA Agreement.
Uredbu Komisije (EU) br. 126/2013 od 13. veljače 2013. o izmjeni Priloga XVII. Uredbi (EZ) br. 1907/2006 Europskog parlamenta i Vijeća o registraciji, evaluaciji, autorizaciji i ograničavanju kemikalija (REACH) [1] treba inkorporirati u Sporazum o EGP-u.
The following indent is added in point 12zc (Regulation (EC) No 1907/2006 of the European Parliament and of the Council) of Chapter XV of Annex II to the EEA Agreement:
U poglavlje XV.
32013 R 0126: Commission Regulation (EU) No 126/2013 of 13 February 2013 (OJ L 43, 14.2.2013, p. 24).’
32013 R 0126: Uredba Komisije (EU) br. 126/2013 od 13. veljače 2013. (SL L 43, 14.2.2013., str. 24.).”
The texts of Regulation (EU) No 126/2013 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.
Tekstovi Uredbe (EU) br. 126/2013 na islandskom i norveškom jeziku, koji se objavljuju u Dodatku o EGP-u Službenom listu Europske unije, vjerodostojni su.
OJ L 43, 14.2.2013, p. 24.
SL L 43, 14.2.2013., str. 24.
Commission Directive 2012/47/EU of 14 December 2012 amending Directive 2009/43/EC of the European Parliament and of the Council as regards the list of defence-related products [1] is to be incorporated into the EEA Agreement.
Direktivu Komisije 2012/47/EU od 14. prosinca 2012. o izmjeni Direktive 2009/43/EZ Europskog parlamenta i Vijeća o popisu obrambenih proizvoda [1] treba inkorporirati u Sporazum o EGP-u.
The following indent is added in point 3q (Directive 2009/43/EC of the European Parliament and of the Council) of Chapter XIX of Annex II to the EEA Agreement:
U poglavlje XIX.
32012 L 0047: Commission Directive 2012/47/EU of 14 December 2012 (OJ L 31, 31.1.2013, p. 43).’
32012 L 0047: Direktiva Komisije 2012/47/EU od 14. prosinca 2012. (SL L 31, 31.1.2013., str. 43.).”
The texts of Directive 2012/47/EU in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.
Tekstovi Direktive 2012/47/EU na islandskom i norveškom jeziku, koji se objavljuju u Dodatku o EGP-u Službenom listu Europske unije, vjerodostojni su.
This Decision shall enter into force on 9 October 2013, provided that all the notifications under Article 103(1) of the EEA Agreement have been made [2], or on the day of the entry into force of Decision of the EEA Joint Committee No 111/2013 of 14 June 2013 [3], whichever is the later.Article 4
Ova Odluka stupa na snagu 9. listopada 2013. pod uvjetom da su sve obavijesti iz članka 103. stavka 1. Sporazuma o EGP-u podnesene [2], ili na dan stupanja na snagu Odluke Zajedničkog odbora EGP-a br. 111/2013 od 14. lipnja 2013.
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.
, ovisno o datumu koji nastupi kasnije.Članak 4. Ova se Odluka objavljuje u odjeljku o EGP-u i u Dodatku o EGP-u Službenom listu Europske unije.
OJ L 31, 31.1.2013, p. 43.
SL L 31, 31.1.2013., str. 43.
OJ L 318, 28.11.2013, p. 12.
SL L 318, 28.11.2013., str. 12.
Commission Decision 2012/32/EU of 19 January 2012 requiring Member States to prohibit the placing on the market of flail-type cutting attachments for portable hand-held brush cutters [1] is to be incorporated into the EEA Agreement.
Odluku Komisije 2012/32/EU od 19. siječnja 2012. kojom se od država članica zahtijeva da zabrane stavljanje na tržište reznih nastavaka koji rade na načelu mlaćenja za prenosive ručne rezače grmlja [1] treba inkorporirati u Sporazum o EGP-u.
The following point is inserted after point 1c (Directive 2006/42/EC of the European Parliament and of the Council) of Chapter XXIV of Annex II to the EEA Agreement:
U poglavlje XXIV.
32012 D 0032: Commission Decision 2012/32/EU of 19 January 2012 requiring Member States to prohibit the placing on the market of flail-type cutting attachments for portable hand-held brush cutters (OJ L 18, 21.1.2012, p. 5).’
32012 D 0032: Odluka Komisije 2012/32/EU od 19. siječnja 2012. kojom se od država članica zahtijeva da zabrane stavljanje na tržište reznih nastavaka koji rade na načelu mlaćenja za prenosive ručne rezače grmlja (SL L 18, 21.1.2012., str. 5.).”
The texts of Decision 2012/32/EU in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.
Tekstovi Odluke 2012/32/EU na islandskom i norveškom jeziku, koji se objavljuju u Dodatku o EGP-u Službenom listu Europske unije, vjerodostojni su.
OJ L 18, 21.1.2012, p. 5.
SL L 18, 21.1.2012., str. 5.
amending Annex II (Technical regulations, standards, testing and certification) and Annex XIII (Transport) to the EEA Agreement
o izmjeni Priloga II. (Tehnički propisi, norme, ispitivanje i potvrđivanje) i Priloga XIII.
THE EEA JOINT COMMITTEE,
(Promet) Sporazumu o EGP-u ZAJEDNIČKI ODBOR EGP-a,
Commission Directive 2012/32/EU of 25 October 2012 amending Council Directive 96/98/EC on marine equipment [1] is to be incorporated into the EEA Agreement.
Direktivu Komisije 2012/32/EU od 25. listopada 2012. o izmjeni Direktive Vijeća 96/98/EZ o pomorskoj opremi [1] treba inkorporirati u Sporazum o EGP-u.
Annexes II and XIII to the EEA Agreement should therefore be amended accordingly,
Priloge II. i XIII. Sporazumu o EGP-u trebalo bi stoga na odgovarajući način izmijeniti,
The following indent is added in point 1 (Council Directive 96/98/EC) of Chapter XXXII of Annex II to the EEA Agreement:
U točku 1. (Direktiva Vijeća 96/98/EZ) poglavlja XXXII. Priloga II.
32012 L 0032: Commission Directive 2012/32/EU of 25 October 2012 (OJ L 312, 10.11.2012, p. 1).’
32012 L 0032: Direktiva Komisije 2012/32/EU od 25. listopada 2012. (SL L 312, 10.11.2012., str. 1.).”
The following indent is added in point 56d (Council Directive 96/98/EC) of Annex XIII to the EEA Agreement:
U točku 56.d (Direktiva Vijeća 96/98/EZ) Priloga XIII. Sporazumu o EGP-u dodaje se sljedeća alineja:
The texts of Directive 2012/32/EU in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.
Tekstovi Direktive 2012/32/EU na islandskom i norveškom jeziku, koji se objavljuju u Dodatku o EGP-u Službenom listu Europske unije, vjerodostojni su.
OJ L 312, 10.11.2012, p. 1.
SL L 312, 10.11.2012., str. 1.
Commission Implementing Regulation (EU) No 1205/2012 of 14 December 2012 amending Regulation (EU) No 802/2010 as regards the company performance [1] is to be incorporated into the EEA Agreement.
Provedbenu uredbu Komisije (EU) br. 1205/2012 od 14. prosinca 2012. o izmjeni Uredbe (EU) br. 802/2010 u vezi s rezultatima kompanije [1] treba uključiti u Sporazum o EEA-u.
The following is added in point 56be (Commission Regulation (EU) No 802/2010) of Annex XIII to the EEA Agreement:
U Prilog XIII. Sporazumu o EGP-u u točku 56.be (Uredba Komisije (EU) br. 802/2010) dodaje se sljedeće:
32012 R 1205: Commission Implementing Regulation (EU) No 1205/2012 of 14 December 2012 (OJ L 347, 15.12.2012, p. 10).’
32012 R 1205: Provedbenom uredbom Komisije (EU) br. 1205/2012 od 14. prosinca 2012. (SL L 347, 15.12.2012., str. 10.).”